Viking TherapeuticsVKTX
那斯達克 · USD
38.07
+0.86
(+2.31%)
盤中 12/12 11:40 (UTC+8)
12/12 11:40 (UTC+8)
Viking TherapeuticsVKTX
38.07
+0.86
(+2.31%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- 0.00
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 0 | 0 | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 0 | - | - | - | - | - | - | - | - | - |
營業費用 | 98,561 | 74,574 | - | 46,238 | 36,556 | - | - | 29,285 | 27,265 | 23,740 |
研發費用 | 89,953 | 60,153 | 41,391 | 30,987 | 22,785 | 23,769 | 24,103 | 20,502 | 18,379 | 13,917 |
推銷及管理費用 | 8,608 | 14,421 | 14,078 | 15,251 | 13,771 | 10,285 | 9,970 | 8,783 | 8,886 | 9,823 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -98,561 | -74,574 | -55,469 | -46,238 | -36,556 | -34,054 | -34,073 | -29,285 | -27,265 | -23,740 |
其他收入及費用 | - | - | 9,840 | 10,821 | 11,616 | 11,804 | 6,717 | 4,680 | 4,731 | 4,515 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -90,787 | -65,561 | -45,629 | -35,417 | -24,940 | -22,250 | -27,356 | -24,605 | -22,534 | -19,225 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -90,787 | -65,561 | -45,629 | -35,417 | -24,940 | -22,250 | -27,356 | -24,605 | -22,534 | -19,225 |
基本每股稅後盈餘(元) | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 | -0.26 | - | -0.23 | -0.19 |
稀釋每股稅後盈餘(元) | -0.81 | -0.58 | -0.41 | -0.32 | -0.23 | -0.20 | -0.26 | -0.25 | -0.22 | -0.19 |
基本平均股數(千股) | 112320.00 | 112134.00 | 112069.00 | 111344.00 | 110911.00 | 110390.00 | 103457.00 | - | 99846.00 | 99010.00 |
稀釋平均股數(千股) | 112320.00 | 112134.00 | 112069.00 | 111344.00 | 110911.00 | 110390.00 | 103457.00 | - | 99846.00 | 99010.00 |
還原基本每股稅後盈餘(元) | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 | -0.26 | - | -0.23 | -0.19 |
還原稀釋每股稅後盈餘(元) | -0.81 | -0.58 | -0.41 | -0.32 | -0.23 | -0.20 | -0.26 | -0.25 | -0.22 | -0.19 |
還原基本平均股數(千股) | 112,320 | 112,134 | 112,069 | 111,344 | 110,911 | 110,390 | 103,457 | - | 99,846 | 99,010 |
還原稀釋平均股數(千股) | 112,320 | 112,134 | 112,069 | 111,344 | 110,911 | 110,390 | 103,457 | - | 99,846 | 99,010 |
EBITDA(千元) | -90,673 | -65,449 | -48,627 | -39,314 | -29,808 | -27,593 | -30,075 | -27,207 | -25,604 | -21,086 |